Key Takeaways
- Utah’s Office of Artificial Intelligence has approved five healthcare firms—including Intermountain Health and University of Utah Health—to pilot AI‑driven clinical services under a temporary regulatory exception.
- The pilot allows AI to handle prescription renewals for chronic conditions, visual evaluations for acne medication, and initial physical‑therapy recommendations, provided each use discloses that AI is running the process.
- Independent third‑party evaluators will assess safety and effectiveness, generating evidence that could shape future state and national AI healthcare regulations.
- Leaders such as Intermountain Health CEO Rob Allen and Stanford scholar Nirav Shah praise the “sandbox” approach for balancing innovation with patient safety, while acknowledging that human oversight remains essential.
- Utah’s initiative expands a 2023 AI policy office that already produced laws on mental‑health chatbots, AI‑generated identity abuse, and disclosure requirements, positioning the state as a national model for responsible AI integration in medicine.
Utah Launches Nationwide‑First AI Healthcare Sandbox
On Monday, October 5, 2026, officials from the Utah Department of Commerce gathered at the State Capitol to announce a groundbreaking pilot program that permits select healthcare providers to deploy artificial intelligence in clinical settings. “This is the only state where a company can say, ‘This is how we’re going to do it safely, responsibly and use this framework to see if it actually works,’” said Dr. Nirav Shah, senior scholar at Stanford University School of Medicine, reflecting a sentiment echoed by participants from across the country and even India. The initiative builds on Utah’s 2023 creation of the Office of Artificial Intelligence, which already holds authority to draft liability‑mitigation agreements with AI firms and to propose regulations based on industry feedback.
Five Companies Receive Temporary Regulatory Clearance
The Office of Artificial Intelligence granted approval to five organizations—Intermountain Health, University of Utah Health, Nolla Health, August Labs, and a fourth unnamed partner—to use AI in scenarios that normally require a state‑issued license. Under a temporary exception to existing regulations, these firms may now offer prescription renewals for chronic illnesses, visual evaluations to support acne‑medication prescribing, and initial physical‑therapy recommendations entirely through AI systems. Each application must clearly disclose that AI is driving the process, a safeguard emphasized by Intermountain Health CEO Rob Allen: “It has the potential to empower doctors to analyze patient data more effectively and to deliver more attentive — and affordable — care.”
AI‑Powered Prescription Renewals Go Live in Utah
August Labs unveiled a Utah‑only feature of its chatbot that enables users to obtain automatic refills for routine, non‑controlled medications at no cost. “Users in the state can navigate the product website without having to wait for a team of clinicians on the back end to respond,” the Deseret News reported, quoting the company’s announcement. Similarly, Nolla Health released a state‑exclusive dermatology app that lets patients receive visual evaluations for acne treatment without awaiting clinician review. These tools aim to reduce administrative delays while maintaining a transparent AI disclosure to patients.
Third‑Party Evaluators Ensure Safety and Accountability
Central to the sandbox model is a network of six independent AI evaluators tasked with reviewing the evidence generated by partnered firms to determine whether their clinical pilots are safe and effective. Mark Sendak, CEO of VegaHealth and one of the evaluators, explained that their role is to “hold parties accountable so that the state’s AI sandbox is used as intended to provide helpful feedback for legislation.” He added, “Clinical tools are higher stakes and they need stronger evidence to earn the trust of health systems and patients. Utah’s sandbox is one of the first places where that evidence is going to be generated.” This oversight mechanism is designed to prevent the program from becoming a high‑risk experiment.
Balancing Innovation with Patient Safety
Intermountain Health CEO Rob Allen emphasized that the sandbox is not about turning hospitals into reckless test beds but about creating a “very structured approach to assure before we deploy those tools that they will work effectively and keep patients safe.” Allen reiterated the organization’s longstanding focus on safety, stating, “Which is what we’ve always focused on.” The structured oversight aims to generate reliable data that can inform both state policy and broader national standards for AI in healthcare.
National Interest and Envy of Utah’s Approach
The pilot has attracted attention far beyond Utah’s borders. Dr. Nirav Shah confessed he is “more than a little jealous” of what Utah is accomplishing, noting that most states lack a formal pathway for companies to collaborate with regulators on rolling out new AI products responsibly. “This is the only state where a company can say, ‘This is how we’re going to do it safely, responsibly and use this framework to see if it actually works,’” Shah told the Deseret News. He believes success in Utah could serve as a proof‑of‑concept for replication nationwide and even in Washington, D.C.
Legislative Foundations and Ongoing Policy Development
Utah’s AI policy office, established in 2023, has already produced concrete legislation, including rules governing mental‑health chatbots, broadened prohibitions on AI‑generated identity abuse, and codified AI disclosure requirements for certain businesses. The current healthcare initiative will specifically examine how the law should address legal liability for physicians who participate in AI‑mediated medical processes. Margaret Woolley Busse, Director of the Utah Department of Commerce, acknowledged that the line separating permissible AI use from overreach remains fluid: “I don’t think that we know that answer yet because the capabilities of AI are changing rapidly… I do know that we always want to have a human involved somewhere. And that’s just really, really important.”
Immediate Impact on Utah Patients
For Utah residents, the changes are already tangible. Patients can now renew prescriptions for chronic conditions through an AI chatbot without waiting for a clinician’s manual approval, and they can receive rapid acne‑treatment assessments via a dermatology app. These conveniences aim to improve access, especially in underserved or rural areas where provider shortages persist. However, the state maintains that human oversight will remain a cornerstone of any AI‑assisted care, ensuring that technology augments rather than replaces the clinician’s judgment.
Looking Ahead: From Sandbox to Standard Practice
Utah’s experiment represents a cautious yet ambitious step toward integrating AI into everyday healthcare. By requiring transparent AI disclosure, mandating third‑party evaluation, and preserving a human‑in‑the‑loop principle, the state seeks to generate robust evidence that could shape future regulations. As Rob Allen succinctly put it, the sandbox allows Utah to “prove it here, then prove it everywhere.” If the pilots demonstrate safety, efficacy, and cost‑effectiveness, the model may well become a blueprint for other states navigating the complex intersection of innovation, liability, and patient trust in the age of artificial intelligence.
https://www.deseret.com/politics/2026/10/05/utah-announces-partnership-with-major-healthcare-providers-to-create-artificial-intelligence-clinical-pilot-programs/

